Karadanote, Inc.
2026 fiscal year July period earnings presentation materials
For the fiscal year ending July 2026, consolidated net sales reached 1,059 million yen (YoY -16.6%, vs. forecast +0.4%), marking an all-time high. Operating income was 218 million yen, net income attributable to owners of parent was 256 million yen (all-time high). FY2027 plans sales of 1,500 million yen, Accelerating growth centered on collaboration with Sumitomo Life Insurance. Expect improvements in consolidated profit following KNLP grouping.
Key Figures
- Sales: 1,059 million yen
- Operating income: 218 million yen
- Net income attributable to owners of parent: 256 million yen
- FY2027 Sales Forecast: 1,500 million yen
- New/restarted incentive program with approx. 9.4% annual yield
AI要約
Overview of Performance
For the fiscal year ending July 2026, full-year sales reached 1,059 million yen (YoY -16.6%, vs. forecast +0.4%). Operating income was 218 million yen, and net income attributable to owners of parent was 256 million yen (record high). While there is some impact from the KNLP group consolidation, the company managed to return to profitability and achieve a record high. The collaboration with Sumitomo Life Insurance was expanded, strengthening cross-sell in wellness-related areas.
Outlook and Growth Strategy
FY2027 targets sales of 1,500 million yen (+41.6%). Focus on growth within the existing group, deepen alliance with Sumitomo Life, and leverage the KNLP consolidation to expand cross-sell. Expand life-event domains such as education, living environment, and end-of-life planning, and continue investments in finance and human resources. Position M&A as a key growth driver to capture non-linear growth opportunities.
Sales Trend
Operating Income Trend
Net Income Trend
FY2027 Forecast vs Actual
Contribution of Group Consolidation
Karadanote, Inc.
Company overview · Stock price · Financial data · All IR
